The reliability of new point-of-care instruments for breath analysis in children with asthma and cystic fibrosis (CF), and healthy controls
- Conditions
- asthmacystic fibrosis (CF)10006436
- Registration Number
- NL-OMON44692
- Lead Sponsor
- Medisch Universitair Ziekenhuis Maastricht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Study Population:
3 groups of children and adolescents aged 6-20 years will be randomly selected:
* 20 healthy children and adolescents
* 20 children and adolescents with asthma
* 20 children and adolescents with CF;
* Children and adolescents aged 6 to 20 years
* Healthy group: See exclusion criteria
* Asthma group: Doctor*s diagnosed asthma
* Cystic Fibrosis group: a diagnosis of cystic fibrosis, confirmed by a sweat test or genetic analysis
* Recent course of prednisone or antibiotics (< 1 month before test)
* Passive smoking
* Other chronic inflammatory disease (e.g. inflammatory bowel disease, rheumatic disease, auto-immune disease)
* Healthy children and adolescents:
* No current or history of respiratory symptoms (by using ISAAC questionnaire)
* No current or history of allergic rhinitis (by using ISAAC questionnaire)
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method